President Donald Trump talked up a joint venture investing up to $500 billion for infrastructure tied to AI by a new partnership formed by OpenAI, Oracle and SoftBank.

Such announcements aren’t without political risks, as OpenAI learned when Trump adviser Elon Musk criticized the deal on the social network he owns.

SoftBank Group CEO Masayoshi Son is shifting his focus away from investments in China and toward the US, as seen with his involvement with President Donald Trump and the recently announced Stargate.

Here are the top takeaways from Trump’s press conference. One of Trump’s first executive actions as the 47th president of the nation was to grant pardons and commutations to all of the defendants convicted over the Jan. 6 Capitol riot, sparking criticism from Democrats who denounced the move.

The initiative announced by President Donald Trump will aim to "secure American leadership in AI" while also creating jobs and economic benefit.

By Sam Nussey and Anton Bridge TOKYO (Reuters) -SoftBank CEO Masayoshi Son's plan to invest billions in AI in the United States shows one way to handle the new Trump administration: go big and deal with the details later.

OpenAI, Oracle and SoftBank formed a new joint venture called Stargate to invest in data centers, building on major U.S. investments in the technology.

Trump said the private sector joint venture will build data centers and create more than 100,000 jobs in the United States.

We may now know roughly how much money SoftBank and OpenAI are contributing toward Stargate, OpenAI's massive data center project.

SoftBank shares surged — on five times the previous day’s volume — on Wednesday after the Japanese investment group landed a starring role in an U.S. artificial intelligence infrastructure buildout package backed by President Donald Trump.

Mr. Trump had claimed the A.I. announcement as an early trophy, taking credit for the companies’ decision to spend up to $500 billion building data centers.

Oracle founder Larry Ellison said the Stargate project, a joint venture with OpenAI and Softbank, will help to fuel the development of a cancer vaccine.